Redburn Atlantic upgraded shares of Lonza Group (OTCMKTS:LZAGY – Free Report) to a strong-buy rating in a research note released on Wednesday,Zacks.com reports.
Separately, The Goldman Sachs Group raised Lonza Group to a “strong-buy” rating in a research report on Wednesday, October 9th.
Read Our Latest Research Report on Lonza Group
Lonza Group Price Performance
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Further Reading
- Five stocks we like better than Lonza Group
- Canada Bond Market Holiday: How to Invest and Trade
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- What is Forex and How Does it Work?
- MarketBeat Week in Review – 11/25 – 11/29
- 3 Best Fintech Stocks for a Portfolio Boost
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.